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Abstract 
National Rotavirus Surveillance in the Gambia was initiated in October 2011 to investigate the prevalence and 
the burden of rotavirus gastroenteritis in infants’ ˂ 5 years of age. The aim was to generate data for decision 
making on the introduction of rotavirus vaccine and to provide base-line data for monitoring the impact of 
vaccination on the burden of rotavirus disease. Vaccination is the most effective method for preventing rotavirus 
infection. Pre-vaccination data, on the prevalence and burden of rotavirus genotypes, is crucial in monitoring 
vaccine efficacy. The Gambia introduced rotavirus vaccine (rota Teq) into routine childhood immunization in 
August 2013. Sentinel surveillance site at the Gambia’s main referral hospital (EFSTH) used the WHO standard 
Case investigation protocol from 2011-2014. Children under 5 years of age, hospitalized mainly for the 
treatment of acute gastroenteritis, were enrolled and stool samples were collected and screened for group A 
rotavirus using Enzyme immunoassay. Confirmed positive cases were genotyped by Polymerase chain reaction 
at the regional Reference lab in Ghana. 
The results shows that from 265 stool samples from enrolled infants (2012-2014), 63 (24%) were ELISA 
positive for rotavirus. Infants’ 0-11 months of age comprised 11% and infants 12-23 months: 8% and 24-59 
months: 5%. Rotavirus was detected throughout the year with a peak prevalence period from January to April.  
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There was mixed rotavirus infection: predominantly genotype G9P [8] in 2013, G12P [8] in 2014. The change in 
serotypes from 2013 to 2014 was statistically significant. There was an unusual genotype G6P [6] observed 
which may be due to the result of Zoonotic infection. These results implicated rotavirus infection as a major 
cause of severe diarrhoea in the Gambia. In the conclusions; we can say that the rotavirus infection is common 
among Gambian infants. The introduction of the vaccine (rota Teq) in 2013 will serve as a safe and effective 
intervention to reduce the severity of rotavirus infection. The established surveillance system will continue to 
monitor and assess the impact and severity of rotavirus disease. 
Keywords: Rotavirus; Genotyping; strains 
1. Introduction  
Rotavirus infection is the highest cause of acute gastroenteritis in children < 5 years of age worldwide [1-2] and 
is more severe than diarrhoea caused any other enteric pathogens [1,2]. Globally, Rotavirus infection causes 
about 527,000 deaths per year. The highest proportion of this mortality occurs in low-income countries. Of all 
deaths caused by rotavirus worldwide, almost half (230,000) are estimated to occur in Africa [3,4]. However, 
there is only fragmentary data on the rotavirus disease burden from Sub-Saharan Africa for authentication of 
these estimates [5]. 
Group A rotaviruses account for the vast majority of human diseases and are classified into different P and G-
types based on two outer capsid proteins, VP4 and VP7, Studies have shown that geographical variation in the P 
and G-type prevalence in different continents, is responsible for the variations in the dominant strains and the 
emergence of unusual strains globally [6,7]. In both antigenic and genetic variations, 27 G types and 35 P types 
have been identified among rotavirus strains of both human and animal origins. 
Bacteria and other parasitic causes of gastroenteritis are well studied in the Gambia, but there is inadequate data 
about viral etiologies of diarrhoea. Hospital based rotavirus surveillance in Edward Francis Small teaching 
Hospital (EFSTH) from 2011 to 2014 showed that rotavirus is the major cause of non-bacterial acute 
gastroenteritis in children and infants (24%). The Gambia joined the African rotavirus network in 2011 to 
conduct hospital based surveillance, to estimate the burden of rotavirus gastroenteritis in children less than 5 
years of age in the main referral hospital of the Gambia, and to provide evidence based data. The evidence based 
data generated from the surveillance will assist policy makers to evaluate the need for the introduction of the 
rotavirus vaccine and to monitor the impact of the vaccine. The main objective of this paper is to describe strain 
diversity and the epidemiology of rotavirus in the Gambia before the introduction of the vaccine. 
2. Methods 
The study was conducted from October 2011 through July 2014 in Edward Francis Small Teaching Hospital, 
formerly known as RVTH. Inclusion and exclusion criteria for diarrhoea cases were as specified in the Regional 
Office for Africa standard operating procedures and WHO Generic protocol [8]. 
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2.1 Patients 
Children less than 5 years of age who were presented with acute gastroenteritis including watery diarrhoea, 
vomiting, abdominal pain, hospitalized, and with disease symptoms, were enrolled into the surveillance. 
Gastroenteritis was defined as the occurrence of 3 or more looser stool than normal with or without vomiting. 
Infants with bloody stool and children above 5 years of age are excluded in the surveillance. 
2.2 Stool sample collection  
From every enrolled child, approximately 6 ml of stool was collected in screw cap stool collection containers 
within 48 hours of hospitalization. Stool samples were transported from the surveillance site to the reference 
laboratory (NPHL) and stored at -20 ˚C until testing. 
2.3 Laboratory diagnosis 
Diagnosis of rotavirus infection was determined by ELISA using the rotavirus Prospect test kit. Positive samples 
and 10% of the negative samples were further characterized at the rotavirus Regional Reference Laboratory in 
Noguchi Medical research centre, Ghana. The samples were analysed by Polyacrylamide gel electrophoresis 
(PAGE) to determine the migration of the RNA (long or Short RNA Bands). To determine the rotavirus 
circulating strains and the samples were also subjected to the Polymerase Chain Reaction (PCR) processes to 
identify the G and P rotavirus circulating strains in the Gambia.  
2. Methods 
The study was conducted from October 2011 through July 2014 in Edward Francis Small Teaching Hospital, 
formerly known as RVTH. Inclusion and exclusion criteria for diarrhoea cases were as specified in the Regional 
Office for Africa standard operating procedures and WHO Generic protocol [8]. 
2.1 Patients 
Children less than 5 years of age who were presented with acute gastroenteritis including watery diarrhoea, 
vomiting, abdominal pain, hospitalized, and with disease symptoms, were enrolled into the surveillance. 
Gastroenteritis was defined as the occurrence of 3 or more looser stool than normal with or without vomiting. 
Infants with bloody stool and children above 5 years of age are excluded in the surveillance. 
2.2 Stool sample collection  
From every enrolled child, approximately 6 ml of stool was collected in screw cap stool collection containers 
within 48 hours of hospitalization. Stool samples were transported from the surveillance site to the reference 
laboratory (NPHL) and stored at -20 ˚C until testing. 
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2.3 Laboratory diagnosis 
Diagnosis of rotavirus infection was determined by ELISA using the rotavirus Prospect test kit. Positive samples 
and 10% of the negative samples were further characterized at the rotavirus Regional Reference Laboratory in 
Noguchi Medical research centre, Ghana. The samples were analysed by Polyacrylamide gel electrophoresis 
(PAGE) to determine the migration of the RNA (long or Short RNA Bands). To determine the rotavirus 
circulating strains and the samples were also subjected to the Polymerase Chain Reaction (PCR) processes to 
identify the G and P rotavirus circulating strains in the Gambia.  
2.4 Data dissemination 
Data generated from the surveillance were regularly shared with the Ministry of Health and Social Welfare of 
the Gambia and WHO both the country office and the regional office. 
2.5 Data analysis 
Data generated were analysed using the EPI info software. This was to determine the prevalence of rotavirus 
infection among infants less than 5 years of age in the Gambia, who were hospitalized for acute gastroenteritis. 
Recording of age distribution and the characterization of the circulating strains were also performed using the 
same software. 
3. Results 
In the rotavirus sentinel site in the Gambia, Edward Francis Small Teaching Hospital, a total of 265 stool 
samples were collected from children less than 5 years of age who were hospitalized with acute gastroenteritis 
from 2012 to 2014. A total of 63 samples were rotavirus positive for the surveillance period of 3 years. 
Table 1:  Number of acute diarrhoea cases by year of hospitalization and rotavirus positive cases during the 
surveillance period from 2012 -2014. 
YEAR OF SURVEILLANCE TOTAL NEGATIVES % POSITIVES % 
2012 19 16 84 3 16 
2013 158 124 78 34 22 
2014 88 62 70 26 30 
TOTAL 265 202 76 63 24 
 
Rotavirus infection was detected in 63/265(24%) of infants that presented with acute gastroenteritis and were 
hospitalized in ESFTH. Age group distribution from analysis of rotavirus infection: 63 infants were rotavirus 
positive with the highest rate of the infection manifested in infants within the age bracket of 0-11 mths’ (11%), 
12-23 months (8%) and 24-56 months (5%).  
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Rotavirus infection is seasonal in the Gambia and it varies across the surveillance period, reflecting the 
difference in the climatic conditions. Although rotavirus infection occurs throughout the year, the prevalence of 
the infection peaked from January to April. 
 
Fig 1: Seasonal Distribution of rotavirus during the surveillance period October- July 2014 
 
   Table 2:  Distribution of rotavirus G and P Genotypes Circulating in The Gambia 2012-2014 
Genotypes 2012 % 2013 % 2014 % Totals%  
G12 P[8] 0 (0%) 6 (23%) 7 (27%) 13(24%) 
G1 P[6] 0 (0%) 0 (0%) 6 (23%) 6 (11%) 
G1 P[8] 0 (0%) 0 (0%) 3 (12%) 3 (5%) 
G1 P[4] 0 (0%) 0 (0%) 1 (4%) 1 (2%) 
G- untypeable 0 (0%) 2 (7%) 5 (21%) 7 (13%) 
G6 P[6] 0 (0%) 1 (4%) 0 (0%) 1 (2%) 
G6 P[8] 0 (0%) 4 (15%) 0 (0%) 4 (7%) 
G9 P[8] 0 (0%) 13 (50%) 0 (0%) 13 (24%) 
P -untypeable 1 (33%) 0 (0%) 1 (4%) 2 (4%) 
G3 P[8] 1 (33%) 0 (0%) 0 (0%) 1 (2%) 
G1 PNT 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
G-Mixed 1 (33%) 3 (10%) 0 (0%) 4 (7%) 
P-Mixed 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Totals 3 (5%) 29 (53%) 23 (42%) 55(100%) 
Note: Percentages rounded to the nearest whole number and the total percentage per year is calculated using the total 
samples genotyped. 
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Between October 2012 and July 2014, 55 rotavirus positive samples were characterized for G and P types. The 
most prevalent genotypes detected during this period were G12P [8] (24%) and G9P [8] (24%) followed by G1P 
[6] (11%), G1P [8] (5%), G6P [8] (7%). Rotavirus genotypes G6P [6], GNTP [6], GNTP [8], G1PNT, G12P [6], 
G2P [8], G3P [8], G1P [4], G12P [4] were detected with a lower prevalence. There are four samples with mixed 
genotypes and 9 samples were partially or un-typable for G and P Genotypes. The distribution of the G and P 
genotypes circulating in the Gambia are shown in the table below. The majority of the circulating strains in the 
Gambia during the period 2012 -2014 were G12P [8] and G9P [8]. 
Rotavirus positive cases by age group analysis revealed differences in the infection rate with increasing age. 
Rotavirus infection within the age bracket of 0-11 months has the highest rotavirus positive rate among the age 
brackets of infants less than 5 years of age. The positivity rate within this age bracket accounted for 44% of all 
the positive cases and has contributed to the high burden of the disease within the age bracket of infants 0-11 
months. In the other age brackets 12-23 months accounted for 33% of the positive cases and 24-59 months 22% 
of the positive cases. 
 
 
 
 
 
 
 
 
Fig 2.  Rotavirus positive cases by age groups 2012 - 2014 
 
5. Discussion 
Rotavirus is not a notifiable disease in the Gambia. However, this surveillance estimates the burden of rotavirus 
infection in the Gambia, based on laboratory data reported through the national rotavirus surveillance. The data 
produced represent only acute diarrhoea cases, based on WHO case definition criteria that were attributed to 
rotavirus by the sentinel surveillance site (ESFTH). 
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The Gambia joined the African Rotavirus Surveillance Network in 2011. From 2011 to July 2014, a total of 265 
samples have been collected from infants below 5 years of age who were hospitalized due to acute diarrheal 
illness. This is similar to the previous study conducted in the URR region in the Gambia  over 3 years (2008-
2010), which showed the prevalence of rotavirus infection in infants below 5 years of age at 10.6% in 2008, 
7.1% in 2009, and 6.5% in 2010 [20]. In a similar study conducted by the Medical Research Council in the 
Gambia from 2008 -2010 the detection rate of rotavirus infection among children was 20% [26]. In this study, 
24% of children who presented with acute gastroenteritis were infected with rotavirus during the surveillance 
period. During this period before the introduction of the rotavirus vaccine (Rota Teq) 63 samples were positive 
for rotavirus with the highest prevalence of infection in infants within the age bracket of 0-11 year (11%). 
Similar to other rotavirus surveillances conducted elsewhere [21, 22], our surveillance confirms the high 
prevalence of rotavirus infection in infants less than 2 years of age. Therefore, there is a need for the long term 
protection that can only be achieved through vaccination. Our study observed that rotavirus infection is 
significantly associated with age and clinical symptoms differ among age groups with vomiting and diarrhoea 
occurring more frequently (4-5 times a day) among younger patients.  
. It was observed that, rotavirus infections occurred throughout the year, with a peak period between January 
and April in the dry season, with a lot of dust blowing around on the dry winds [23,24]. The seasonality of 
rotavirus infection in The Gambia is similar to that observed in other countries in West Africa.  
During the study period the most prevalent rotavirus genotypes observed were G12P [8] and G9P [8], each with 
24% of the total samples collected. This is in line with the prevalence rate in some other African countries 
according to the Africa rotavirus surveillance report 2006-2008. The incidences recorded: in Uganda G9P [8] 
(16%), Cameron G9P [8] (19%) and G12P [8] (10%) and Ethiopia G12P [8] (8%). These genotype results are 
different from the genotypes obtained by MRC during their rotavirus study in one of the regions in rural Gambia 
(URR) from 2008-2010. The predominant genotypes from their study were G2P [6] 28%, G1P [8] 26% and G1P 
[10] 10% and the rare identified genotypes were 1% [26]. There was one unusual genotype observed during the 
surveillance period, G6P [6], which might be due to potential reassortment between human and animal rotavirus 
strains due to zoonotic infection. Mixed infection was observed in the G-types of two samples during the study 
period (G1G12P [8] and G12G1P [8].  The genotype results also show a number of untypeable rotavirus strains 
(15%). It is possible that these are unusual rotavirus strains of animal origin. Alternatively they could be due to 
the result of primers used for typing by reverse transcriptase polymerase chain reaction that do not represent 
consensus sequences in these animal derived rotavirus strains [7 ]. 
The majority of the positive samples processed on Poly Acrylamide Gel Electrophoresis (PAGE) were 
predominantly long RNA (77%) and few were found to have short electrophoretic pattern (23%). 
The Gambia introduced the rotavirus vaccine (Rota Teq) in 2013, but we have not started the rotavirus vaccine 
impact study and the intussusceptions study. As a result, the information on vaccine received by infants during 
the surveillance period was not collected. Due to these factors the potential effects of vaccination on the 
incidence of acute rotavirus gastroenteritis and the prevailing rotavirus types could not be determined. 
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There are some limitations in the surveillance activities especially in the recruitment of cases and sample 
collection. One of the limitations of this surveillance is the potential error in the estimation of the rotavirus 
incidence rate, as the surveillance was conducted in only one site, which does not include other hospitals that 
admit paediatric acute gastroenteritis cases. The only surveillance site was located in the only major referral 
hospital in the capital city Banjul (ESFTH). As a result the data generated may not be a true representation of 
the prevalence and burden of rotavirus in the Gambia. Therefore there is a need to increase the surveillance sites 
to other areas in the greater Banjul as well as in the rural areas for better understanding of the true burden of 
rotavirus infection in the Gambia. The rotavirus-positive samples that were collected and genotyped may not 
represent the circulating rotavirus strains throughout the Gambia. However, the predominant strains were 
captured and their diversity has been demonstrated. 
6. Conclusion 
These data highlight the prevalence of Rotavirus in infants who were hospitalized with acute gastroenteritis and 
Diarrhoea which has been demonstrated in the extreme ends of the country [26]. Rotavirus is common in 
Gambian infants, hence the need for safe and effective interventions. The predominant circulating strains have 
changed from 2013 to 2014, G12P [8] and G9P [8] respectively. It is important to study the diversity of 
rotavirus strains and to monitor the impact of rotavirus vaccination on the severity of rotavirus infection in the 
Gambia. 
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